Loading…
Alzheimer's Breakthrough Sunshine Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Alzheimer's Breakthrough Sunshine Act This bill amends the Internal Revenue Code to exclude from gross income for seven years amounts received from the sale of certain drugs for treating Alzheimer's disease and related dementias. The exclusion applies to the sale of a drug approved or licensed as a disease-modifying treatment for Alzheimer's disease and that has been designated as a breakthrough therapy under the Federal Food, Drug, and Cosmetic Act. The drug must be sold through an arm's length transaction by a holder of the approved application for the drug.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2016 · second_quarter · Health Issues
S. 2508/ HR 4460: Youth Sports Concussion Act HR 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 S. 2782/ HR 1859: Ensuring Childrens Access to Specialty Care Act S. 849 / HR 292: The Advancing Research for Neurological Diseases Act S. 2873 / HR 5395: The Expanding Capacity for Health Outcomes (ECHO) for Act HR 5366: Alzheimers Breakthrough Sunshine Act Maintenance/expansion of Graduate Medical Education (GME); NIH Funding; concussion related issues.
Referred to the House Committee on Ways and Means.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $280,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
2016 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 6, the 21st Century Cures Act H.R. 5073/S. 2067, the EUREKA Act H.R. 5366, the Alzheimer's Breakthrough Sunshine Act Senate Biomedical Innovation Initiative
Client expense: $245,500 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2016 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 6, the 21st Century Cures Act H.R. 5073/S. 2067, the EUREKA Act H.R. 5366, the Alzheimer's Breakthrough Sunshine Act Senate Biomedical Innovation Initiative
Client expense: $245,500 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2016 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 6, the 21st Century Cures Act H.R. 5073/S. 2067, the EUREKA Act H.R. 5366, the Alzheimer's Breakthrough Sunshine Act Senate Biomedical Innovation Initiative
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2016 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 6- 21st Century Cures initiative S. 2067,the Ensuring Useful Research Expenditures is Key for Alzheimers (EUREKA) Act Senate HELP Committee companion to 21st Century Cures H.R. 5366 - the Alzheimers Breakthrough Sunshine Act
Client expense: $28,000 · Firm income: Not reported
Government targets: Administration on Aging, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2016 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 6, the 21st Century Cures Act H.R. 5073/S. 2067, the EUREKA Act H.R. 5366, the Alzheimer's Breakthrough Sunshine Act Senate Biomedical Innovation Initiative
Client expense: $180,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2016 · second_quarter · Health Issues
S. 2508/ HR 4460: Youth Sports Concussion Act HR 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 S. 2782/ HR 1859: Ensuring Childrens Access to Specialty Care Act S. 849 / HR 292: The Advancing Research for Neurological Diseases Act S. 2873 / HR 5395: The Expanding Capacity for Health Outcomes (ECHO) for Act HR 5366: Alzheimers Breakthrough Sunshine Act Maintenance/expansion of Graduate Medical Education (GME); NIH Funding; concussion related issues.
Client expense: Not reported · Firm income: $280,000
Government targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
2016 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 6- 21st Century Cures initiative S. 2067,the Ensuring Useful Research Expenditures is Key for Alzheimers (EUREKA) Act Senate HELP Committee companion to 21st Century Cures H.R. 5366 - the Alzheimers Breakthrough Sunshine Act
Client expense: $29,500 · Firm income: Not reported
Government targets: Administration on Aging, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office